Oligonucleotide Array Synthesis via Intramolecular Transesterification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for synthesizing oligonucleotides, such as PCR primers, often lack rigorous purification steps, especially for short oligonucleotides, relying on simple ethanol precipitation or cartridge separation, which may not ensure high fidelity and purity, necessitating additional quality control measures like MALDI-TOF mass spectrometry and capillary gel electrophoresis.
Innovation Solution
The method involves synthesizing oligonucleotides on a high-density oligonucleotide array using a reverse-orientation RNA monomer with an orthogonal 2′-OH protecting group, followed by base-induced intramolecular transesterification to release oligonucleotides with authentic 3′-hydroxy functionality, and employing cleavable linkers and monomers to facilitate controlled release and purification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If conventional solid-supported phosphoramidite approach is used with simple ethanol precipitation or cartridge separation, then production cost and process simplicity are improved, but oligonucleotide purity and fidelity deteriorate
Solution Approach 1:
The patent segments the synthesis process into two distinct phases: (1) oligonucleotide assembly on solid support with standard protecting groups, and (2) selective cleavage of the oligonucleotide from the support using a separate deprotection reagent. This segmentation allows the support to remain intact for reuse while the oligonucleotide is released in a purified state, resolving the contradiction between process simplicity and product purity.
Solution Approach 2:
The patent extracts the oligonucleotide from the solid support through selective cleavage using a deprotection reagent that removes the oligonucleotide while leaving the support intact. This extraction process inherently purifies the oligonucleotide by separating it from support-bound contaminants and incomplete synthesis products, thereby improving purity without requiring complex additional purification steps.
2Manufacturing precision
If rigorous purification steps are implemented for short oligonucleotides, then oligonucleotide fidelity is improved, but production time and complexity increase
Solution Approach 1:
The patent merges the cleavage and deprotection steps into a single operational phase. The deprotection reagent simultaneously cleaves the oligonucleotide from the support and removes protecting groups, achieving both release and purification in one step. This merging eliminates the need for separate rigorous purification steps, thereby maintaining high fidelity while reducing production time.
Solution Approach 2:
The solid support is designed to facilitate self-purification during the cleavage process. The support structure and selective cleavage mechanism work together to automatically separate full-length oligonucleotides from incomplete synthesis products and contaminants, providing self-service purification that reduces manual intervention and time requirements while maintaining high fidelity.
3Productivity
If high-density oligonucleotide arrays are used for parallel synthesis, then productivity is improved, but device complexity and synthesis control difficulty increase
Solution Approach 1:
The patent employs universal solid support structures and reagents that can be applied across all positions on the high-density array. The same deprotection reagent and cleavage mechanism work uniformly for thousands of oligonucleotide synthesis reactions simultaneously, enabling parallel processing without requiring position-specific complexity. This universality maintains high productivity while managing device complexity through standardized protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the efficient production and purification of high-fidelity oligonucleotides with authentic 3′-hydroxyl groups, enhancing primer purity and quantity, and allowing for the use of photolithographic strategies to produce arrays of probes and primers with improved fidelity and yield.
Implementation Method 1
the 2′-OH protecting group is removed to allow base-induced intramolecular transesterification. The transesterification reaction causes release of the synthesized probe with an authentic 3′-hydroxy functionality
Data Source
AI summary
The present invention provides massively parallel oligonucleotide synthesis and purification for applications that utilize large collections of defined high-fidelity oligonucleotides (e.g., from about 101 to about 105 different sequences, generally between 25-160 bases in length).